Literature DB >> 7039551

Henoch-Schönlein purpura: simultaneous demonstration of IgA deposits in involved skin, intestine, and kidney.

J A Stevenson, L A Leong, A H Cohen, W A Border.   

Abstract

Recent reports indicate that circulating IgA immune complexes may play a primary role in the pathogenesis of Henoch-Schönlein vasculitis and are responsible for the granular deposits of IgA seen in biopsy specimens of skin and kidney. A patient had classic Henoch Schönlein syndrome, including hematuria, purpura, and abdominal pain; tissue taken simultaneously from the small intestine, skin, and kidney was examined by light immunofluorescent, and electron microscopy. Granular deposits of IgA were found in small-vessel walls of the intestinal tissue and skin, and in the glomerular mesangium. This provides further support for the notion that IgA deposits produce tissue injury in intestine, skin, and kidney in Henoch-Schönlein syndrome.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7039551

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  5 in total

Review 1.  Gastrointestinal manifestations of Henoch-Schonlein Purpura.

Authors:  Ellen C Ebert
Journal:  Dig Dis Sci       Date:  2008-03-20       Impact factor: 3.199

2.  Intestinal IgA deposition in Henoch-Schönlein purpura with severe gastro-intestinal manifestations.

Authors:  S Kato; K Ebina; H Naganuma; S Sato; S Maisawa; H Nakagawa
Journal:  Eur J Pediatr       Date:  1996-02       Impact factor: 3.183

3.  Schonlein-Henoch purpura and pancreatitis.

Authors:  C F Diaz
Journal:  Dig Dis Sci       Date:  1995-04       Impact factor: 3.199

4.  Palpable leg purpura and renal failure in a 23-year-old man.

Authors:  F P Quismorio; R H Blau; M Akmal; M Koss
Journal:  West J Med       Date:  1984-01

5.  A case of Henoch-Schönlein purpura in disseminated tuberculosis.

Authors:  B G Han; S O Choi; S J Shin; H Y Kim; S H Jung; K H Lee
Journal:  Korean J Intern Med       Date:  1995-01       Impact factor: 2.884

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.